Live from the NIH registry
Studies recruiting near Athens right now
Top 25 of 74 recruiting studies, sorted by proximity — each links to its official registry page
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
Infectious Disease Consultants of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: National Cancer Institute (NCI)
Neuroimaging Approaches to Improve Prediction of Smoking Initiation and Nicotine Escalation in Young Adult ENDS Users
Message Exposure (Sequence: Regular Then Flavor), Message Exposure (Sequence: Flavor Then Regular)
N/A
Interventional 180 participants sought
UGA Bio-imaging Research Center — Athens, Georgia (0.9 mi)
· Sponsor: University of Georgia
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 120 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi)
· Sponsor: Pfizer
Harnessing Communication Preferences
Intellectual Disability, Autism Spectrum Disorder
N/A
Interventional 60 participants sought
University of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: Joel E. Ringdahl
Mom Multi Postnatal Supplementation Trial
Postnatal Care
N/A
Interventional 80 participants sought
UGA Clinical & Translational Unit — Athens, Georgia (0.9 mi)
· Sponsor: Perelel Inc.
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Northeast Georgia Medical Center Braselton — Braselton, Georgia (25.1 mi)
· Sponsor: SWOG Cancer Research Network
Multi-level Predictors of Structural Racism and Discrimination and Associations With Health and Well-being Across the Life Course in Diverse Families
Racially/Ethnically Diverse Families From Urban Settings
N/A
Observational 631 participants sought
University of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: University of Colorado, Denver
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: NRG Oncology
Dyadic Financial Incentive Treatments for Dual Smoker Couples
Smoking, Cigarette
Phase 2
Interventional 900 participants sought
University of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: University of Oklahoma
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
Atrial Fibrillation (AF), Persistant Atrial Fibrillation
N/A
Interventional 699 participants sought
Piedmont Athens Regional — Athens, Georgia (0.9 mi)
· Sponsor: Boston Scientific Corporation
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Early Breast Cancer
Phase 3
Interventional 1,400 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Phase 3
Interventional 4,220 participants sought
University Blood & Cancer Center, LLC — Athens, Georgia (0.9 mi)
· Sponsor: Stemline Therapeutics, Inc.
Cottonseed Oil Versus Matched PUFA Effects
Dyslipidemia, Overweight and Obesity
N/A
Interventional 90 participants sought
University of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: University of Georgia
CLOZAPINE Response in Biotype-1
Schizophrenia, Schizoaffective Disorder
Phase 4
Interventional 524 participants sought
University of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: University of Texas Southwestern Medical Center
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC)
Phase 2
Interventional 160 participants sought
Local Institution - 0170 — Athens, Georgia (0.9 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Relapsed or Refractory Multiple Myeloma
Phase 3
Interventional 810 participants sought
Local Institution - 0211 — Athens, Georgia (0.9 mi)
· Sponsor: Celgene
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2
Interventional 56 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: SWOG Cancer Research Network
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2
Interventional 66 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Locally Advanced Solid Tumors, Metastatic Solid Tumors
Phase 1, Phase 2
Interventional 500 participants sought
University Cancer and Blood Center — Athens, Georgia (0.9 mi)
· Sponsor: Turning Point Therapeutics, Inc.
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi)
· Sponsor: NRG Oncology
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,000 participants sought
Northeast Georgia Medical Center Braselton — Braselton, Georgia (25.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Intermittent Cottonseed Oil Consumption
Dyslipidemia, Overweight and Obesity
N/A
Interventional 75 participants sought
University of Georgia — Athens, Georgia (0.9 mi)
· Sponsor: University of Georgia
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
Atrial Fibrillation (AF)
N/A
Interventional 423 participants sought
Piedmont Heart of Athens — Athens, Georgia (0.9 mi)
· Sponsor: Vektor Medical
Prospective Study to Assess a Diagnostic Aid for Cancer
Cancer
N/A
Observational 1,650 participants sought
Pulmonary & Sleep Specialists of Northeast Georgia, P.C — Winder, Georgia (20.3 mi)
· Sponsor: Harbinger Health